Peter Carson
Washington, DCNPI 1588755227
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $672,838 of the $734,227 with a category attached, or 91.6%. Boehringer Ingelheim International GmbH accounts for 69.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $417,591 and has fallen 95.8% since, to $17,334 in 2025.
Across 319 payments — averaging $2301.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$507K
- AbbVie$87K
- Impulse Dynamics (USA) Inc.$68K
- Livanova USA, Inc.$63K
- Merck$7K
- Amgen$1K
- plus $1K from 4 others
Across 32 payments — averaging $2134.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$28K
- AbbVie$17K
- Merck$17K
- Novartis$4K
- Currax Pharmaceuticals LLC$3K
What the payments were for
- Consulting fees$672,83892%
- Speaking & faculty fees$7,9101%
- Travel & lodging$50,6527%
- Food & beverage$2,8270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 143 | $506,555 |
| AbbVie | 76 | $86,668 |
| Impulse Dynamics (USA) Inc. | 21 | $68,460 |
| Livanova USA, Inc. | 54 | $63,235 |
| Merck | 7 | $6,702 |
| Amgen | 8 | $1,268 |
| Boehringer Ingelheim Canada Ltd.ltee | 6 | $640 |
| Abiomed | 1 | $500 |
| Boehringer Ingelheim | 2 | $184 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$503,799
- OPTIMIZER$127,220
- Rinvoq$45,600
- VNS - Vitaria$44,560
- VNS Therapy$18,675
- OPTIMIZER SMART SYSTEM$1,400
- TRADJENTA$1,375
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.